ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,807.31
-1.61%
S&P 500
5,631.22
0.28%
Dow Jones
40,211.72
0.53%
US Dollar vs Yen
158.6215
0.30%
Brent Oil
83.70
-0.76%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Viridian Therapeutics Inc (VRDN)

  7. Viridian Therapeutics Inc (VRDN) ニュース

VRDN

Viridian Therapeutics (VRDN)

Viridian Therapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:VRDN
日付受信時刻ニュースソース見出しコード企業名
2023/02/0808 : 56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRDNViridian Therapeutics Inc
2023/02/0808 : 46Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:VRDNViridian Therapeutics Inc
2023/02/0808 : 35Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:VRDNViridian Therapeutics Inc
2023/02/0722 : 00GlobeNewswire Inc.Viridian Therapeutics to Participate in the SVB Securities Virtual Global Biopharma ConferenceNASDAQ:VRDNViridian Therapeutics Inc
2023/02/0621 : 07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VRDNViridian Therapeutics Inc
2023/02/0621 : 00GlobeNewswire Inc.Viridian Appoints Scott Myers as President and Chief Executive OfficerNASDAQ:VRDNViridian Therapeutics Inc
2023/02/0408 : 13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRDNViridian Therapeutics Inc
2023/02/0306 : 05GlobeNewswire Inc.Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:VRDNViridian Therapeutics Inc
2023/01/2707 : 03Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VRDNViridian Therapeutics Inc
2023/01/2608 : 05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRDNViridian Therapeutics Inc
2023/01/1907 : 59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRDNViridian Therapeutics Inc
2023/01/0822 : 00GlobeNewswire Inc.Viridian Announces Positive Data from Ongoing Phase 1/2 Trial Evaluating Low Dose VRDN-001 in Patients with Thyroid Eye Disease (TED)NASDAQ:VRDNViridian Therapeutics Inc
2023/01/0606 : 05GlobeNewswire Inc.Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VRDNViridian Therapeutics Inc
2023/01/0322 : 00GlobeNewswire Inc.Viridian Therapeutics to Webcast Presentation at the 41st Annual J.P. Morgan Healthcare ConferenceNASDAQ:VRDNViridian Therapeutics Inc
2022/12/2306 : 43Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRDNViridian Therapeutics Inc
2022/12/2121 : 00GlobeNewswire Inc.Viridian Therapeutics Announces First Patient Enrolled in the ‘THRIVE’ Phase 3 Trial in Patients With Thyroid Eye DiseaseNASDAQ:VRDNViridian Therapeutics Inc
2022/12/0806 : 05GlobeNewswire Inc.Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VRDNViridian Therapeutics Inc
2022/12/0608 : 29TipRanksLooking for Red-Hot Takeover Candidates? Here Are 2 Stocks on Analysts’ RadarNASDAQ:VRDNViridian Therapeutics Inc
2022/12/0607 : 35TipRanksViridian Therapeutics (VRDN) Gets a Buy from OppenheimerNASDAQ:VRDNViridian Therapeutics Inc
2022/12/0212 : 05TipRanksSVB Securities Sticks to Their Buy Rating for Viridian Therapeutics (VRDN)NASDAQ:VRDNViridian Therapeutics Inc
2022/11/2821 : 00GlobeNewswire Inc.Viridian Therapeutics To Participate In The Evercore ISI HealthCONx ConferenceNASDAQ:VRDNViridian Therapeutics Inc
2022/11/1708 : 46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRDNViridian Therapeutics Inc
2022/11/1616 : 55TipRanksViridian Therapeutics (VRDN) Gets a Buy from SVB SecuritiesNASDAQ:VRDNViridian Therapeutics Inc
2022/11/1520 : 50TipRanksAnalysts Are Bullish on Top Healthcare Stocks: Galectin Therapeutics (GALT), Viridian Therapeutics (VRDN)NASDAQ:VRDNViridian Therapeutics Inc
2022/11/1508 : 05TipRanksJMP Securities Remains a Buy on Viridian Therapeutics (VRDN)NASDAQ:VRDNViridian Therapeutics Inc
2022/11/1502 : 55TipRanksWedbush Remains a Buy on Viridian Therapeutics (VRDN)NASDAQ:VRDNViridian Therapeutics Inc
2022/11/1421 : 10Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VRDNViridian Therapeutics Inc
2022/11/1421 : 01GlobeNewswire Inc.Viridian Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate UpdatesNASDAQ:VRDNViridian Therapeutics Inc
2022/11/1420 : 59GlobeNewswire Inc.Viridian Announces Positive Data from Ongoing Phase 1/2 Trial Evaluating VRDN-001 in Patients with Thyroid Eye Disease (TED)NASDAQ:VRDNViridian Therapeutics Inc
2022/11/0821 : 05GlobeNewswire Inc.Viridian Therapeutics to Participate in Guggenheim 4th Annual Neuro/Immunology Conference on November 15thNASDAQ:VRDNViridian Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:VRDN

最近閲覧した銘柄

LSE
05IS
Mando Mach.gdr
LSE
0Y6X
Medtronic
LSE
0OPB
Mckesson Europe
LSE
0OG1
Zts Sabinov As
LSE
0KXY
Altareit Sca
LSE
UFO
Alien Metals
AMEX
GAMR
Amplify Video Game Tech ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有